First Time Loading...

Taisho Pharmaceutical Holdings Co Ltd
TSE:4581

Watchlist Manager
Taisho Pharmaceutical Holdings Co Ltd Logo
Taisho Pharmaceutical Holdings Co Ltd
TSE:4581
Watchlist
Price: 999 999.9999 JPY Market Closed
Updated: May 13, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Cash Flow Statement

19.2B
-53%
Operating Cash Flow
Growth Rates:
1 Year
-34%
3 Years
-50%
5 Years
-60%
7 Years
-55%
10 Years
-59%
-34.9B
-29%
Investing Cash Flow
Growth Rates:
1 Year
-
3 Years
-
5 Years
-
7 Years
-143%
10 Years
-194%
-10.7B
+1%
Financing Cash Flow
Growth Rates:
1 Year
-26%
3 Years
+12%
5 Years
+31%
7 Years
+42%
10 Years
-2%

Cash Flow Statement
Taisho Pharmaceutical Holdings Co Ltd

Rotate your device to view
Cash Flow Statement
Currency: JPY
Sep-2013 Mar-2014 Sep-2014 Mar-2015 Sep-2015 Mar-2016 Sep-2016 Mar-2017 Sep-2017 Mar-2018 Sep-2018 Mar-2019 Sep-2019 Mar-2020 Sep-2020 Mar-2021 Sep-2021 Mar-2022 Sep-2022 Mar-2023 Sep-2023
Operating Cash Flow
Net Income
47 253
51 316
45 907
40 162
37 489
35 809
38 637
41 956
40 116
48 070
82 979
64 484
31 958
30 311
27 750
22 976
10 852
21 398
32 403
29 498
25 246
Depreciation & Amortization
12 070
12 387
12 803
12 938
12 824
12 473
12 031
11 670
11 526
11 380
11 318
11 290
11 633
16 695
21 653
22 041
22 396
23 074
23 578
24 648
27 202
Other Non-Cash Items
(9 786)
(9 213)
(8 735)
(8 718)
(7 625)
(6 511)
(7 407)
(10 268)
(8 896)
(10 986)
(43 948)
(32 856)
(2 924)
(9 434)
(5 416)
(2 842)
(4 057)
(10 125)
(10 510)
(5 392)
588
Cash Taxes Paid
8 674
7 047
13 415
16 424
12 283
9 181
11 318
11 340
11 476
11 684
16 194
14 928
14 467
14 140
6 807
6 188
8 801
8 688
9 488
10 205
5 853
Cash Interest Paid
10
2
2
2
2
2
2
1
1
2
2
2
17
119
964
173
(632)
158
202
173
171
Change in Working Capital
(2 260)
5 743
(5 307)
(10 904)
(5 671)
1 285
(983)
(3 293)
(13 588)
(8 613)
(1 697)
(23 740)
(14 725)
4 421
(5 199)
(149)
7 523
(5 841)
(16 419)
(7 782)
(33 818)
Cash from Operating Activities
47 277
N/A
60 233
+27%
44 668
-26%
33 478
-25%
37 017
+11%
43 056
+16%
42 278
-2%
40 065
-5%
29 158
-27%
39 851
+37%
48 652
+22%
19 178
-61%
25 942
+35%
41 993
+62%
38 788
-8%
42 026
+8%
36 714
-13%
28 506
-22%
29 052
+2%
40 972
+41%
19 218
-53%
Investing Cash Flow
Capital Expenditures
(11 601)
(14 860)
(12 535)
(5 764)
(6 123)
(8 214)
(10 570)
(8 830)
(5 739)
(5 013)
(4 646)
(4 914)
(6 172)
(9 121)
(11 643)
(14 372)
(13 656)
(14 389)
(24 774)
(50 379)
(42 766)
Other Items
(266)
(7 138)
(7 778)
(12 398)
(7 289)
(3 448)
(3 808)
7 469
(2 110)
(14 895)
73 351
70 958
(134 701)
(97 960)
35 276
12 414
469
7 326
25 711
23 249
7 870
Cash from Investing Activities
(11 867)
N/A
(21 998)
-85%
(20 313)
+8%
(18 162)
+11%
(13 412)
+26%
(11 662)
+13%
(14 378)
-23%
(1 361)
+91%
(7 849)
-477%
(19 908)
-154%
68 705
N/A
66 044
-4%
(140 873)
N/A
(107 081)
+24%
23 633
N/A
(1 958)
N/A
(13 187)
-573%
(7 063)
+46%
937
N/A
(27 130)
N/A
(34 896)
-29%
Financing Cash Flow
Net Issuance of Common Stock
(82)
(110)
(105)
(97)
(108)
(10 097)
(10 097)
(100)
(78)
(96)
(352)
(341)
(73)
(48)
(48)
(41)
(44)
(43)
(35)
(34)
(47)
Net Issuance of Debt
(413)
(121)
(158)
(161)
(108)
(236)
(113)
(45)
(190)
(103)
(99)
(86)
843
(1 337)
(1 493)
(686)
(226)
(254)
644
(1 064)
(585)
Cash Paid for Dividends
(9 656)
(8 894)
(8 914)
(8 900)
(8 887)
(8 903)
(8 032)
(7 974)
(8 770)
(8 771)
(8 771)
(8 773)
(9 569)
(9 586)
(8 790)
(8 787)
(7 648)
(7 415)
(7 532)
(8 206)
(8 549)
Other
(339)
(314)
(286)
(285)
(288)
(289)
(285)
(285)
(896)
(897)
(6 270)
(6 267)
(721)
(725)
(1 834)
(1 832)
(2 474)
(2 345)
(1 573)
(1 573)
(1 553)
Cash from Financing Activities
(10 490)
N/A
(9 439)
+10%
(9 463)
0%
(9 443)
+0%
(9 391)
+1%
(19 525)
-108%
(18 527)
+5%
(8 404)
+55%
(9 934)
-18%
(9 867)
+1%
(15 492)
-57%
(15 467)
+0%
(9 520)
+38%
(11 696)
-23%
(12 165)
-4%
(11 346)
+7%
(10 392)
+8%
(10 057)
+3%
(8 496)
+16%
(10 877)
-28%
(10 734)
+1%
Change in Cash
Effect of Foreign Exchange Rates
1 859
1 221
28
1 031
1 073
(640)
(1 652)
(348)
700
67
(76)
(570)
60
177
(409)
(317)
495
780
2 516
1 595
1 179
Net Change in Cash
26 779
N/A
30 017
+12%
14 920
-50%
6 904
-54%
15 287
+121%
11 229
-27%
7 721
-31%
29 952
+288%
12 075
-60%
10 143
-16%
101 789
+904%
69 185
-32%
(124 391)
N/A
(76 607)
+38%
49 847
N/A
28 405
-43%
13 630
-52%
12 166
-11%
24 009
+97%
4 560
-81%
(25 233)
N/A
Free Cash Flow
Free Cash Flow
35 676
N/A
45 373
+27%
32 133
-29%
27 714
-14%
30 894
+11%
34 842
+13%
31 708
-9%
31 235
-1%
23 419
-25%
34 838
+49%
44 006
+26%
14 264
-68%
19 770
+39%
32 872
+66%
27 145
-17%
27 654
+2%
23 058
-17%
14 117
-39%
4 278
-70%
(9 407)
N/A
(23 548)
-150%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 136,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.